Title: Best Practices for OINDP Pharmaceutical Development Programs Leachables and Extractables
1Best Practices for OINDP Pharmaceutical
Development Programs Leachables and
Extractables II. OINDP Container Closure
Systems PQRI Leachables Extractables Working
Group PQRI Training Course September 20-21,
2006 Washington, DC
2Container Closure System Components
- Primary Packaging Components, which are or may be
in direct contact with the dosage form. These
include containers (e.g., ampules, vials,
bottles), container liners, closures (e.g., screw
caps, stoppers, metering valves), closure liners,
stopper overseals, container inner seals,
administration ports, overwraps, etc. - Secondary Packaging Components, which are not or
will not be in direct contact with the dosage
form. These include container labels,
administration accessories, shipping containers,
etc. Note that even though secondary packaging
components are not in direct contact with the
drug product, they may still contribute
leachables under certain conditions.
3Critical Components
- Critical components of an OINDP container
closure system are defined as those that contact
either the patient or the formulation, components
that affect the mechanics of the overall
performance of the device, or any necessary
secondary protective packaging.
4MDI Critical Components
- Dose metering valve
- Metering chamber
- Stem(s)
- Seals/gaskets
- Sealing rings
- Canister
- Coated?
- Mouthpiece/actuator
MDI Schematic Provided by Bespak Europe
5OINDP Container Closure System Components
6DPI
Images provided by Bespak Europe
7DPI Critical Components ARCHaler
Drug reservoir
Air in
Dose metering arc
Note that the ARCHaler is a complete
fabrication. Any resemblance to any existing
drug product or container closure system is
purely coincidental.
8What are some potential sources for leachables
and extractables?
- Chemical additives present in individual
elastomeric/polymeric container closure system
components, including contaminants in such
additives (e.g. PAHs and N-nitrosamines). - Monomers and higher molecular weight oligomers
derived from incomplete polymerization reactions. - Migrants from secondary packaging components,
such as inks and label adhesives. - Surface residues, such as heavy oils and
degreasing agents on the surfaces of metal
canisters and containers. - Chemical additives on the surfaces of container
closure system component fabrication machinery,
such as mould release agents, antistatic and
antislip agents, etc. - Chemical entities from the storage environment
(i.e., very secondary packaging components),
such as volatiles from cardboard shipping
containers or plastic storage bags.
9Examples of Chemical Additives
10Whats in a name?
Abietic acid
11Additive Chemistry
Hydroperoxide (ROOH)
Irgafos 168
12Reaction of Hindered Phenol with Singlet Oxygen
1O2
13Information Required
- The elastomeric/polymeric or other material
constituting the principal structure of the
component (e.g., High Density Polyethylene,
Ethylene-Propylene-Diene rubber, stainless steel,
etc.) - The polymerization/cross-linking/curing process,
or processes, for the component base polymer,
including any chemical additives employed. - The compounding/fabrication process, or
processes, including any additives designed to
assist in compounding/fabrication. - All individual chemical additives/ingredients in
the component, including the composition and
chemistry of each individual additive. - Any cleaning/washing processes for finished
components, including knowledge of cleaning,
washing, or other agents. - The storage/shipping environment for both
components and drug product, if the potential for
environmental leaching exists.
14Raw Materials Supply Chain
15Raw Materials - Supply Chain
16Component Fabrication
Images provided by Bespak Europe
Moulding machines
17Deep Drawing Process
deep-drawing tool
metal rolls
Images provided by Presspart
18Deep Drawing Process
finished canisters
Images provided by Presspart
degreasing process
19Rubber Formulation A (Sulfur Cured)
- Ingredient
-
- CALCINED CLAY 8.96
- BLANC FIXE (barium sulfate) 25.80
- CREPE 38.22
- BROWN SUB MB 16.84
- 1722 MB 2.11
- ZINC OXIDE 4.04
- 2, 2 METHYLENE-BIS (6-TERTIARY BUTYL-4-ETHYL
PHENOL) 0.56 - COUMARONE-INDENE RESIN 1.12
- PARAFFIN 1.12
- TETRAMETHYLTHIURAM MONOSULFIDE 0.11
- ZINC 2-MERCAPTOBENZOTHIAZOLE 0.29
- SULFUR 0.84
-
20What do we know?
- Carbon black is a known source of PAHs and has
also been shown to be involved in N-nitrosamine
formation in rubber (special cases). - Thiurams are known precursors of N-nitrosamines.
- 2-Mercaptobenzothiazole is a known special
case. - Paraffin and Coumarone-indene resin are natural
product materials and are likely complex mixtures
of related structures. - Individual additives are likely GC-able.
21Sulfur Cured Rubber Extractables Profile by
GC/MS
22Polypropylene Formulation
- Ingredient wt
- Primary Stabilizers
- Tetrakis (methylene(3,5-di-t-butyl-
- 4-hydroxyhydrocinnamate)) methane
- Irganox 1010 (Ciba) 0.08 wt
- Anox 20 (Great Lakes)
- Secondary Stabilizers
- Bis(2,4-di-t-butylphenyl)pentaerythritol
diphosphite - Ultranox 626 (GE) 0.05 wt
23Polypropylene Formulation
- Ingredient
- Corrosion Inhibitors
- Calcium Stearate 114-50 (Ferro) 0.03 - 0.4 wt
- Antistatic
- Vegetable oil derived
- 90 alpha monoglycerides (soybean)
- Pationic 901 (Patco) 0.3 wt
- Dimodan HS-KA (Danisco)
- Nucleating Agents
- 3,4 -dimethyl dibenzylidene sorbitol
- Millad 3988 (Milliken) 0.2 wt
24What do we know?
- Polypropylene is known to contain many soluble
oligomers. - Individual additives will likely require analysis
by HPLC based methods. - Individual additives could be both chemically
complex and have complex degradation chemistries. - No reason to suspect the presence of special
cases
25Polypropylene Extractables Profile by LC/UV/MS
26Polypropylene Extractables Profile by GC/MS
27Rubber Formulation B (Peroxide Cured)
- Ingredient
-
- IMSIL A25 (silicone dioxide) 24.01
- MISTRON CYPRUBOND (magnesium silicate) 19.21
- BROMOBUTYL 2030 38.42
- VISTALON 404 (ethylene propylene copolymer) 9.61
- WHITE OIL 2 1.44
- 420 BLUE MB 0.12
- TITANIUM DIOXIDE 1.68
- PARAFFIN 0.96
- MAGNESIUM OXIDE 0.60
- STEARIC ACID 0.48
- POLYETHYLENE WAX 1.44
- P-800 2.03
-
-
28Rubber Formulation B (Peroxide Cured)
- Ingredient
-
- CONTENTS OF 420 BLUE MB
- SBR-3
- PIGMENT BLUE 15
- ANOX 9
-
- CONTENTS OF P-800
- 2,5 DI METHYL-2, 5-DI (T-BUTYL PEROXIDE)
HEXANE 68.00 - PRECIPITATED SILICA 32.00
-
-
29What do we know?
- Registry Number 78-63-7
- Formula C16 H34 O4
- CA Index Name Peroxide, (1,1,4,4-tetramethyl-1,
4-butanediyl)bis(1,1-dimethylethyl) (9CI) - Other Names Peroxide, (1,1,4,4-tetramethyltetra
methylene)bistert-butyl (6CI,8CI)
(1,1,4,4-Tetramethyltetramethylene)bis(tert-butyl
peroxide) 101XL 2,5-Bis(tert-butyldioxy)-2,5-dim
ethylhexane 2,5-Bis(tert-butylperoxy)-2,5-dimethy
lhexane 2,5-Di(t-butylperoxy)-2,5-dimethylhexane
2,5-Di(tert-butylperoxy)-2,5-dimethylhexane
2,5-Di-tert-butyl-2,5-dimethylhexyl peroxide
2,5-Dimethyl-2,5-bis(tert-butyldioxy)hexane
2,5-Dimethyl-2,5-bis(tert-butylperoxy)hexane
2,5-Dimethyl-2,5-di(t-butylperoxy)hexane
2,5-Dimethyl-2,5-di(tert-butylperoxy)hexane
2,5-Dimethyl-di(tert-butyl)peroxyhexane
2,5-Dimethylhexane-2,5-di-tert-butylperoxide
2,5-Methyl-2,5-di(tert-butylperoxy)hexane 25B40
AD AD 40C APO APO 40S C 15 C 15 (peroxide)
C 8 C 8 (vulcanizer) C 8A CR 05 CT 8 CT 8
(crosslinking agent) HC 4 HC 4 (peroxide)
Interox DHBP Interox DHBP 45IC/G Kayahexa AD
Kayahexa AD 40 Kayahexa AD 40C L 101 LX 101
Link-Cup DBPH Luperco 101X45 Luperco 101XL
Luperox 101 Luperox 101XL Luperox 101XL45
Lupersol 101 Lupersol 101XL Lupersol L 101 NSC
38203 Perhexa 2.5B Perhexa 2.5B40 Perhexa 25B
Perhexa 25B40 RC 4 RC 4 (peroxide) RC 450P RC
8 RPZ 101 Sanperox APO TC 8 TC 8 (catalyst)
Trigonox 101 Trigonox 101-40D Trigonox
101-40MD-GR Trigonox 101-50 Trigonox 101E10
Trigonox 101E5 Trigonox XQ 8 Varox Varox 50
Varox DBPH Varox DBPH 50 Varox Liquid Yinox
101 - 2261 references in chemistry database (7 related
to analytical studies)
30Peroxide Cured Rubber Extractables Profile by
GC/MS
31Summary of PQRI Recommendations
- The pharmaceutical development team should obtain
all available information on the composition and
manufacturing/fabrication processes for each
component type to the extent possible, and
determine which components are critical,
before beginning extractables and leachables
studies on a given OINDP and its associated
container/closure system components. - Component formulation should inform component
selection. - Risk Assessment should be performed during the
selection of components and materials. - Extractables testing, including Controlled
Extraction Studies and the development and
validation of Routine extractables testing
methods, should be accomplished for all critical
OINDP components.
32Best Practices for OINDP Pharmaceutical
Development Programs Leachables and
Extractables Early Safety Assessment of Potential
Leachables PQRI Leachables Extractables
Working Group Douglas J. Ball, MS, DABT PQRI
Training Course September 20-21, 2006 Washington,
DC
33Early Evaluation Process
- Form a team
- Pharmaceutical Sciences
- Analytical Chemistry
- Toxicology
- Regulatory
- Review Drug Product Specifications
- Determine and agree what are the Critical
Components of the DP - Is the actuator trigger a Critical Component?
34Supplier Evaluation
- Is the Supplier willing to share information?
- What type of data will be shared
- Controlled extraction data
- ISO 10993/USP lt87gt, lt88gt reports
- MSDS
- Other toxicology data
- May require confidentiality agreements
- Allow time to get agreements in place
- Can the Supplier provide medical grade materials
- Has the Supplier filed DMFs for the materials?
- Is Supplier willing to provide DMF
- Can non-medical grade material be used
- Can the Supplier provide information on prior use
of material for approved DP?
35ExampleDrug Product with Delivery System
- An already approved DP is being revamped
- New/Improved delivery system
- Global Registration anticipated
- DP evaluation team formed
- Based on DP configuration, 5 Critical Components
have been Identified
36Critical Components
Critical Component Contact Supplier Identified Confidentiality Agreement
Ring Seal Patient/Product Yes No
Plunger Insert Product Yes Yes
Plunger Seal Product Yes Yes
Chamber Product Yes Yes
Valve Seal Product Yes In Process
37Ring Seal
- Supplier has limited experience with
pharmaceutical applications - Is hesitant to provide detailed information on
material - Trade secret may compromise exclusivity of
material if data shared with DP manufacturer - Will not disclose
- Chemical/Physical composition
- Safety/Risk information
38Ring Seal - Options
- Pharmaceutical Sciences
- Material is optimal and compatible with the
delivery system - Pharm Sci prefers to stay with this material
- Alternatives that were evaluated were not
considered optimal - Analytical Sciences
- Will need to conduct a preliminary extraction
study - Will have no data from supplier to compare with
- Toxicology
- Evaluate extractable profile for potential red
flags - PNAs, nitrosamines, MBT, etc.
- Potential for extensive in silico risk assessment
of extractable profile
39Ring Seal Issues/Risks
- FTE burn by Analytical Chemistry and Toxicology
- Potential exists that an unacceptable extractable
is identified - May need to identify alternative material
- Potential delay in development/registration of DP
40Plunger Insert
- Material is HDPE
- Chemical information supplied
- Physical Properties - Yes
- Composition - Yes
-
- Toxicology information supplied
- Indirect Food Additive cross reference
41Plunger Insert - Composition
Chemical Component Range (weight )
Ethylene-Octene-1 copolymer CAS 26221-73-8 (Sanctioned under 21 CFR 177.1520) 99.92 99.97
Octadecyl 3,5-di-tert-butyl 4 hydroxyhydrocinnamate CAS 2082-79-3 (Sanctioned under 21 CFR 178.2010) 0.025 0.065
Calcium Stearate CAS 1592-23-0 (Sanctioned under 21 CFR 178.2010) 0.005 0.015
Safe use of polyolefin articles intended for
direct food contact Safe use of
antioxidants/stabilizers in polymers for indirect
food contact
42Plunger Seal
- Material is PP
- Chemical information supplied
- Physical Properties - No
- Composition - Yes
-
- Toxicology information supplied
- None
43Plunger Seal - Compositon
Chemical Component Content (Weight )
1-propene, polymer with ethene CAS 9010-79-1 94.48
Dimethyl succinate polymer with 4-hydroxy-2,2,6,6-tetramethyl-1-piperidineethanol CAS 65447-77-0 0.2
2,2-oxamido bis-ethyl 3-(3,5-di-tert-butyl-4-hydroxyphenol)propionate CAS 70331-94-1 0.07
di(stearyl) penta-erythritol diphosphite CAS 3806-34-6 0.1
synthetic hydrotalcite CAS 11097-59-9 0.05
calcium stearate CAS 1592-23-0 0.1
LLDPE CAS 25087-34-7 5
44Issues
- No Toxicology data supplied
- Inquire on availability of toxicology data
- ISO/USP test results
- MSDS
- Other
- Limited Chemical Profile
- Additional data requested
- e.g., antioxidants
45Resolution
- Analytical Chemistry
- In-house controlled extraction studies will be
conducted to obtain comprehensive profile - Toxicology
- Can perform initial assessment on information
supplied - May determine bad actors when additional
information from controlled extraction studies
are evaluated
46Initial Risk Assessment (1)
- Obtain chemical structures of each extractant
- Conduct SAR Analysis
- DEREK - Deductive Estimation of Risk from
Existing Knowledge - MultiCase
- SAR will typically report genotoxicity,
mutagenicity, carcinogenicity - Limited value for reprotoxicology, irritation,
sensitization -
47Risk Assessment (2)
- Perform Literature Search
- Agency for Toxic Substances and Disease Registry
- Chemical Hazards Response Information System
- Material Safety Datasheet Database
- New Jersey Hazardous Substance Fact Sheet
- Micromedex
- National Toxicology Program Testing Information
- National Institute of Occupational Safety and
Health Registry of Toxic effects of Chemical
Substances - Occupational Safety and Health Technical Links to
Safety and Health Topics - Toxnet (National Library of Medicine Specialized
Information Services) - Registry of Toxic Effects of Chemical Substances
- Center for Drug Evaluation and Research and the
Integrated Risk Information System - National Institute of Environmental Health
Sciences - Environmental Protection Agency Integrated Risk
Information System - Technical Information Exchange Syste
48Risk Assessment (3)
- Evaluate available inforamation
- Assume worst case scenario all extract leaches
into DP - Provide initial risk assessment to team
- Identify any/all potential issues
- Make recommendations on further use of material
based on risk assessment profile
49Conclusions
- Data from suppliers may be limited in scope
- May not provide a total extract profile
- May not provide significant toxicity information
- May require a preliminary extraction study
- Obtain more comprehensive profile of the material
- Risk Assessment is only as good as the data that
is available